TrumpRx launches discount drug portal, aims to cut costs but skeptics doubt sweeping savings

President Trump unveiled TrumpRx, a direct-to-consumer site offering discounts on about 40 branded medicines from five major drugmakers with GoodRx backing; experts say savings may be muted for many since insurance plans and deductibles often yield lower costs, and pricing details remain unclear. The administration touts it as transformative, but critics warn it could curb competition and that broader Medicare drug-price negotiations would be more effective. A potential Express Scripts agreement could expand coverage if the regulatory environment allows, signaling that Congress may need to act to count purchases toward deductibles.